Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech vs. Shorts -- Ignore unavailable to you. Want to Upgrade?

To: RWReeves who wrote (240)	10/9/1999 3:29:00 PM
From: Biomaven	Respond to of 427

Best to avoid falling on sword..PI trials of falling on sword were halted because of AE's. I had heard that the problem came when they tried to do the double blind ... <g> Seriously, though, if GLIA had come out a little while back and announced their product was being detained on import (as they're now apparently conceding), I doubt if the stock price tomorrow would have been a whole lot different. And it's not just the first-timers that have manufacturing troubles with the FDA - look at the mess Abbot got into, for example. The stock is definitely going to be on sale tomorrow - one just has to decide if this is an aberrational misstep, or whether they're going to be perennially tripping over things. Peter